Immune Response and the Tumor Microenvironment: How They Communicate to Regulate Gastric Cancer

키워드

참고문헌 (75)

1. Parkin DM, "The global health burden of infection-associated cancers in the year 2002", Int J Cancer, 118, pp.3030~3044 (2006)
2. Yuasa Y., "Control of gut differentiation and intestinal-type gastric carcinogenesis", Nat Rev Cancer, 3, pp.592~600 (2003)
3. Balkwill F, "Mantovani A. Inflammation and cancer: back to Virchow?", Lancet, 357, pp.539~545 (2001)
4. Koebel CM, "Adaptive immunity maintains occult cancer in an equilibrium state", Nature, 450, pp.903~907 (2007)
5. Correa P, "Human gastric carcinogenesis: a multistep and multifactorial process. First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention", Cancer Res, 52, pp.6735~6740 (1992)
6. Correa P., "Helicobacter pylori and gastric carcinogenesis", Am J Surg Pathol, 19(Suppl 1), pp.S37~S43 (1995)
7. Peek RM Jr, "Helicobacter pylori and gastrointestinal tract adenocarcinomas", Nat Rev Cancer, 2, pp.28~37 (2002)
8. Huang JQ, "Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer", Gastroenterology, 114, pp.1169~1179 (1998)
9. Cai X, "Helicobacter felis eradication restores normal architecture and inhibits gastric cancer progression in C57BL", 6 mice, 2005, pp.128, 1937~1952
10. Nardone G, "Effect of Helicobacter pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis", Gut, 44, pp.789~799 (1999)
11. Wang TC, "Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer", Gastroenterology, 118, pp.36~47 (2000)
12. Lofgren JL, "Lack of commensal flora in Helicobacter pylori-infected INS-GAS mice reduces gastritis and delays intraepithelial neoplasia", Gastroenterology, 140, pp.210~220 (2011)
13. Parsonnet J, "Helicobacter pylori infection and the risk of gastric carcinoma", N Engl J Med, 325, pp.1127~1131 (1991)
14. Salama NR, "Life in the human stomach:persistence strategies of the bacterial pathogen Helicobacter pylori", Nat Rev Microbiol, 11, pp.385~399 (2013)
15. Parsonnet J, "Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection", Gut, 40, pp.297~301 (1997)
16. Tsutsumi R, "Attenuation of Helicobacter pylori CagA x SHP-2 signaling by interaction between CagA and C-terminal Src kinase", J Biol Chem, 278, pp.3664~3670 (2003)
17. Crabtree JE, "Induction of interleukin-8 secretion from gastric epithelial cells by a cagA negative isogenic mutant of Helicobacter pylori", J Clin Pathol, 48, pp.967~969 (1995)
18. Brandt S, "NF-kappaB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein", Proc Natl Acad Sci U S A, 102, pp.9300~9305 (2005)
19. Viala J, "Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island", Nat Immunol, 5, pp.1166~1174 (2004)
20. Yu J, "Relationship between Helicobacter pylori babA2 status with gastric epithelial cell turnover and premalignant gastric lesions", Gut, 51, pp.480~484 (2002)
21. Prinz C, "Key importance of the Helicobacter pylori adherence factor blood group antigen binding adhesin during chronic gastric inflammation", Cancer Res, 61, pp.1903~1909 (2001)
22. Franco AT, "Regulation of gastric carcinogenesis by Helicobacter pylori virulence factors", Cancer Res, 68, pp.379~387 (2008)
23. Ogura K, "Virulence factors of Helicobacter pylori responsible for gastric diseases in Mongolian gerbil", J Exp Med, 192, pp.1601~1610 (2000)
24. Radin JN, "Helicobacter pylori VacA induces programmed necrosis in gastric epithelial cells", Infect Immun, 79, pp.2535~2543 (2011)
25. Yamasaki E, "Helicobacter pylori vacuolating cytotoxin induces activation of the proapoptotic proteins Bax and Bak, leading to cytochrome c release and cell death, independent of vacuolation", J Biol Chem, 281, pp.11250~11259 (2006)
26. Niwa T, "Inflammatory processes triggered by Helicobacter pylori infection cause aberrant DNA methylation in gastric epithelial cells", Cancer Res, 70, pp.1430~1440 (2010)
27. Fischer W, "Virulence mechanisms and persistence strategies of the human gastric pathogen Helicobacter pylori", Curr Top Microbiol Immunol, 337, pp.129~171 (2009)
28. Asfaha S, "Mice that express human interleukin-8 have increased mobilization of immature myeloid cells, which exacerbates inflammation and accelerates colon carcinogenesis", Gastroenterology, 144, pp.155~166 (2013)
29. Pollard JW, "Tumour-educated macrophages promote tumour progression and metastasis", Nat Rev Cancer, 4, pp.71~78 (2004)
30. Oguma K, "Activated macrophages promote Wnt signalling through tumour necrosis factor-alpha in gastric tumour cells", EMBO J, 27, pp.1671~1681 (2008)
31. Biswas SK, "Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm", Nat Immunol, 11, pp.889~896 (2010)
32. Fehlings M, "Comparative analysis of the interaction of Helicobacter pylori with human dendritic cells, macrophages, and monocytes", Infect Immun, 80, pp.2724~2734 (2012)
33. El-Omar EM, "The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer", Nature, 412, pp.99~ (2001)
34. Figueiredo C, "Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma", J Natl Cancer Inst, 94, pp.1680~1687 (2002)
35. Fox JG, "Inflammation, atrophy, and gastric cancer", J Clin Invest, 117, pp.60~69 (2007)
36. Tu S, "Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloidderived suppressor cells in mice", Cancer Cell, 14, pp.408~419 (2008)
37. Gabrilovich DI, "Myeloid-derived suppressor cells as regulators of the immune system", Nat Rev Immunol, 9, pp.162~174 (2009)
38. Taketo MM., "Role of bone marrow-derived cells in colon cancer:lessons from mouse model studies", J Gastroenterol, 44, pp.93~102 (2009)
39. Stairs DB, "Deletion of p120-catenin results in a tumor microenvironment with inflammation and cancer that establishes it as a tumor suppressor gene", Cancer Cell, 19, pp.470~483 (2011)
40. El-Omar EM, "Polymorphisms in Toll-like receptor genes and risk of cancer", Oncogene, 27, pp.244~252 (2008)
41. Yokota S, "Helicobacter pylori lipopolysaccharides upregulate toll-like receptor 4 expression and proliferation of gastric epithelial cells via the MEK1", 2-ERK1, Infect Immun, pp.2010, 78[DOI]
42. Hold GL, "A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors", Gastroenterology, 132, pp.905~912 (2007)
43. Huang B, "Listeria monocytogenes promotes tumor growth via tumor cell toll-like receptor 2 signaling", Cancer Res, 67, pp.4346~4352 (2007)
44. Canedo P, "The interferon gamma receptor 1 (IFNGR1) -56C", T gene polymorphism is associated with increased risk of early gastric carcinoma, 2008, pp.57, 1504~1508
45. Syu LJ, "Transgenic expression of interferon-γ in mouse stomach leads to inflammation, metaplasia, and dysplasia", Am J Pathol, 181, pp.2114~2125 (2012)
46. Quante M, "Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth", Cancer Cell, 19, pp.257~272 (2011)
47. Varon C, "Helicobacter pylori infection recruits bone marrow-derived cells that participate in gastric preneoplasia in mice", Gastroenterology, 142, pp.281~291 (2012)
48. Judd LM, "Gastric cancer development in mice lacking the SHP2 binding site on the IL-6 family coreceptor gp130", Gastroenterology, 126, pp.196~207 (2004)
49. Howlett M, "Differential regulation of gastric tumor growth by cytokines that signal exclusively through the coreceptor gp130", Gastroenterology, 129, pp.1005~1018 (2005)
50. Jenkins BJ, "Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-beta signaling", Nat Med, 11, pp.845~852 (2005)
51. Tye H, "STAT3-driven upregulation of TLR2 promotes gastric tumorigenesis independent of tumor inflammation", Cancer Cell, 22, pp.466~478 (2012)
52. Zhu J, "Differentiation of effector CD4 T cell populations", Annu Rev Immunol, 28, pp.445~489 (2010)
53. Gooden MJ, "The prognostic influence of tumour-infiltrating lymphocytes in cancer:a systematic review with meta-analysis", Br J Cancer, 105, pp.93~103 (2011)
54. Gajewski TF, "Innate and adaptive immune cells in the tumor microenvironment", Nat Immunol, 14, pp.1014~1022 (2013)
55. Robinson K, "Helicobacter pyloriinduced peptic ulcer disease is associated with inadequate regulatory T cell responses", Gut, 57, pp.1375~1385 (2008)
56. Arnold IC, "Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory T cells", J Clin Invest, 121, pp.3088~3093 (2011)
57. Hahm KB, "Conditional loss of TGF-beta signalling leads to increased susceptibility to gastrointestinal carcinogenesis in mice", Aliment Pharmacol Ther, 16(Suppl 2), pp.115~127 (2002)
58. Monteleone G, "Induction and regulation of Smad7 in the gastric mucosa of patients with Helicobacter pylori infection", Gastroenterology, 126, pp.674~682 (2004)
59. Tu SP, "IFN-gamma inhibits gastric carcinogenesis by inducing epithelial cell autophagy and T-cell apoptosis", Cancer Res, 71, pp.4247~4259 (2011)
60. Zhou Y, "IL-17A versus IL-17F induced intracellular signal transduction pathways and modulation by IL-17RA and IL-17RC RNA interference in AGS gastric adenocarcinoma cells", Cytokine, 38, pp.157~164 (2007)
61. Shibata T, "Genetic polymorphism of interleukin-17A and -17F genes in gastric carcinogenesis", Hum Immunol, 70, pp.547~551 (2009)
62. Iida T, "Tumor-infiltrating CD4+Th17 cells produce IL-17 in tumor microenvironment and promote tumor progression in human gastric cancer", Oncol Rep, 25, pp.1271~1277 (2011)
63. Wilke CM, "Deciphering the role of Th17cells in human disease", Trends Immunol, 32, pp.603~611 (2011)
64. Pinchuk IV, "Stromal cells induce Th17 during Helicobacter pylori infection and in the gastric tumor microenvironment", PLoS One, 8, pp.e53798~ (2013)
65. Kennedy CL, "The molecular pathogenesis of STAT3-driven gastric tumourigenesis in mice is independent of IL-17", J Pathol, 225, pp.255~264 (2011)
66. Liu T, "Increased circulating Th22 and Th17cells are associated with tumor progression and patient survival in human gastric cancer", J Clin Immunol, 32, pp.1332~1339 (2012)
67. Shimatani T, "Gastric acidity in patients with follicular gastritis is significantly reduced, but can be normalized after eradication for Helicobacter pylori", Helicobacter, 0, pp.256~265 (2005)
68. Zayakin P, "Tumor-associated autoantibody signature for the early detection of gastric cancer", Int J Cancer, 132, pp.137~147 (2013)
69. Kido M, "Helicobacter pylori promotes the production of thymic stromal lymphopoietin by gastric epithelial cells and induces dendritic cell-mediated inflammatory Th2 responses", Infect Immun, 78, pp.108~114 (2010)
70. Sangiolo D, "Cytokine induced killer cells as promising immunotherapy for solid tumors", J Cancer, 2, pp.363~368 (2011)
71. Gao Q, "Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection", J Clin Oncol, 25, pp.2586~2593 (2007)
72. Galon J, "Type, density, and location of immune cells within human colorectal tumors predict clinical outcome", Science, 313, pp.1960~1964 (2006)
73. Greenwald RJ, "The B7 family revisited", Annu Rev Immunol, 23, pp.515~548 (2005)
74. Nomi T, "Clinical significance and therapeutic potential of the programmed death-1 ligand", programmed death-1 pathway in human pancreatic cancer, 2007, pp.13, 2151~2157
75. Wolchok JD, "Development of ipilimumab:a novel immunotherapeutic approach for the treatment of advanced melanoma", Ann N Y Acad Sci, 1291, pp.1~13 (2013)

관련 논문AI추천